Menu

Aerie Pharmaceuticals, Inc. AERI

Full chart Compare
Set alert

Price alert · AERI

All alert types
15.25 +15.25

Day range unavailable

52-week range unavailable

Revenue & Expenses

Revenue by
Other Income → Expenses: $1.04MProduct → Revenue: $112.13MExpenses → Selling, General & Admin: $137.81MExpenses → Research & Development: $75.84MExpenses → Interest Expense: $28.90MExpenses → Income Tax: $593.00KGross Profit → Expenses: $167.29MRevenue → Gross Profit: $167.29MRevenue → Cost of Revenue: $26.85MLicense → Revenue: $82.00MNet Loss → Expenses: $74.81MOther Income$1.04MGross Profit$167.29MNet Loss$74.81MCost of Revenue$26.85MExpenses$243.14MSelling, General & Admin$137.81MResearch & Development$75.84MInterest Expense$28.90MIncome Tax$593.00KRevenue$194.13MProduct$112.13MLicense$82.00M

Latest period ending Dec 31, 2021 · select a line to chart its full history

Annual income statement

AERI annual income statement
Fiscal yearFY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018FY 2017 Dec 31, 2017
194.13M83.14M69.89M24.18M0
194.13M83.14M69.89M24.18M0
26.85M25.33M4.83M641.00K0
167.29M57.80M65.06M23.54M0
213.64M213.50M252.55M233.28M145.69M
75.84M74.01M91.38M86.12M72.08M
137.81M137.18M138.40M120.61M56.91M
-46.35M-155.69M-187.49M-209.74M-145.69M
593.00K5.25M-90.00K3.00K-1.76M
-74.81M-183.10M-199.58M-232.57M-145.10M
-74.81M-183.10M-199.58M-232.57M-145.10M
-74.81M-183.10M-199.58M-232.57M-145.10M
-74.81M-183.10M-199.58M-232.57M-145.10M
-1.61-3.99-4.39-5.58-4.11
-1.61-3.99-4.39-5.58-4.11
-1.61-3.99-4.39-5.58-4.11
-74.22M-177.86M-199.67M-232.57M-146.86M
-74.22M-177.86M-199.67M-232.57M-146.86M
46.34M45.90M45.43M41.66M35.32M
46.34M45.90M45.43M41.66M35.32M